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Abstract
Metabolic syndrome is associated with an increased risk of developing cardiovascular diseases and plasminogen activator 
inhibitor 1 (PAI-1) overexpression may play a significant role in this process. A positive correlation between adipose tissue gene 
expression of PAI-1 and its serum concentration has been reported. Furthermore, high serum levels of thyroid hormones (T3 and 
T4) and PAI-1 have been observed in obese children. The present study evaluates the impact of thyroid hormone treatment on 
white adipose tissue PAI-1 gene expression and its serum concentration. Male Wistar rats (60 days old) were treated for three 
weeks with T4 (50 µg/day, Hyper) or with saline (control). Additionally, 3T3-L1 adipocytes were treated for 24 h with T4 (100 nM) 
or T3 (100 nM). PAI-1 gene expression was determined by real-time PCR, while the serum concentration of PAI-1 was measured 
by ELISA using a commercial kit (Innovative Research, USA). Both the serum concentration of PAI-1 and mRNA levels were 
similar between groups in retroperitoneal and epididymal white adipose tissue. Using 3T3-L1 adipocytes, in vitro treatment with 
T4 and T3 increased the gene expression of PAI-1, suggesting non-genomic and genomic effects, respectively. These results 
demonstrate that thyroid hormones have different effects in vitro and in vivo on PAI-1 gene expression in adipocytes.
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Adipose tissue has an essential energy storage func-
tion due to its triacylglyceride reserve but is now also 
recognized to be an important secretory organ. Adipose 
tissue produces the adipokines involved in glucose toler-
ance and insulin sensitivity (adiponectin, TNF-α , interleu-
kin-6, and resistin), vascular homeostasis (plasminogen 
activator inhibitor 1, PAI-1), and inflammatory and stress 
responses (TNF-α , interleukin-6, haptoglobin, and metal-
lothionein), among others (1).
PAI-1 is the main inhibitor of the fibrinolytic system, 
which is formed by several proteins that regulate plas-
min generation, whose function is to cleave fibrin and to 
activate extracellular matrix-metalloproteinases, further 
eliminating fibrin clots (2). Fibrin clot formation in the en-
dothelial lesion site is a critical process in the maintenance 
of vascular integrity. Increasing evidence indicates that 
higher plasma PAI-1 levels induce the development of 
thromboembolytic complications (3) and cardiovascular 
disease. Adipose tissue PAI-1 gene expression and serum 
concentration have been reported in several pathological 
conditions, such as obesity, hyperinsulinemia, and hyper-
glycemia (4,5).
The thyroid hormones T4 (thyroxin) and T3 (tri-
iodothyronine) also have cardiovascular effects, probably 
through the regulation of circulating clotting proteins and 
fibrinolytic activity (6); however, the mechanisms lead-
ing to cardiovascular and thromboembolytic diseases in 
thyroid dysfunction are controversial. Some reports have 
described an increase in serum PAI-1 concentration in 
hyperthyroidism, whereas others did not detect any dif-
ferences (7-9).
In the present study, we determined the effects of in 
vivo treatment of rats with the thyroid hormone T4 on gene 
expression and the serum concentration of PAI-1. Addition-
ally, the effects of T3 and T4 on the gene expression of 
PAI-1 in 3T3-L1 adipocytes were also evaluated.
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Material and Methods
Animals and treatments
Male Wistar rats (60 days old) were obtained from the 
Universidade Federal de São Paulo, Centro de Desenvol-
vimento de Modelos Experimentais (CEDEME). They were 
maintained in the animal house of the Division of Nutrition 
Physiology, under controlled conditions of light (12-h light/
dark cycle, lights on at 6 am) at 22 ± 1°C, and with free 
access to food and water. Care and use of the laboratory 
animals were in accordance with NIH guidelines and the 
local Ethics Committee at Universidade Federal de São 
Paulo (protocol #0079/07).
The rats were allowed to acclimatize for 1 week before 
the beginning of the experiment, and then were randomly 
divided into 2 groups: 1) control group that received a 
daily intraperitoneal (ip) injection of vehicle (N = 10), and 
2) hyperthyroid rat group (Hyper) that received a daily ip 
injection of T4 (50 mg/rat; N = 10) (10).
The animals received a diet prepared according to the 
recommendations of the American Institute of Nutrition 
(AIN-93M) (11). This diet was composed of casein (14%), 
cornstarch (71.1%), soybean oil (5%), non-nutritive cellulose 
fiber (5%), AIN-93 mineral mix (3.5%), AIN-93 vitamin mix 
(1%), choline bitartrate (0.25%), L-cystine (0.18%), butyl-
hydroquinone (0.0008%), and energy (3.8 kcal/g). Body 
weight and food intake were measured weekly.
Experimental procedures
All animals were treated and fed for 21 days. Euthanasia 
was performed in the fed condition by decapitation with-
out sedation. Trunk blood was collected and immediately 
centrifuged, and serum was stored at -80°C before the 
determination of T4, T3, and PAI-1. The retroperitoneal 
(RET) and epididymal (EPI) white adipose tissues were 
removed completely and weighed, immediately frozen in 
liquid nitrogen, stored at -80°C, and finally used for PAI-1 
mRNA quantification.
Cell culture
3T3-L1 cells were obtained from the American Type 
Culture Collection and cultured at 37°C in a humidified 
atmosphere of 5% CO2/95% air. The cells were grown in 
Dulbecco’s modified Eagle’s medium (Invitrogen, USA) 
containing 25 mM glucose, 1 mM pyruvate, 4.02 mM L-
alanyl-glutamine, and 10% fetal calf serum (Sigma, USA). 
Differentiation of the cells was initiated 24 h after conflu-
ence by incubation in a growth medium containing 0.25 μM 
dexamethasone, 0.5 mM 3-isobutyl-1-methyl-xanthine, and 
5 μg/mL insulin (Sigma) for 2 days. This was followed by 
10 days in a growth medium containing 5 μg/mL insulin. On 
the 10th day, fetal calf serum was removed for 6 h and the 
adipocytes were then treated for 24 h with 100 nM T3 (N = 
12) or 100 nM T4 (N = 12) (12). In the control group (N = 
12), the medium was changed, but no agent was added.
RNA extraction and real-time polymerase chain 
reaction
Total RNA was isolated from RET and EPI samples 
using Trizol (Invitrogen) following manufacturer recom-
mendations. Concentrations of RNA were determined by 
measuring absorbance at 260 nm. The purity of RNA was 
determined by calculating the absorbance ratios at 260 
and 280 nm, as well as by electrophoresis on an ethidium 
bromide-stained gel.
PAI-1 mRNA from RET and EPI and 3T3-L1 cells were 
quantified by real-time PCR. RNA samples were previ-
ously treated with DNAse (DNAfree, Promega, USA). One 
microgram of each sample was reverse transcribed using 
an M-MLV reverse transcriptase kit (Promega), and cDNA 
was synthesized in a final volume of 50 µL. The relative 
level of PAI-1 mRNA was quantified in real time using the 
SYBR green primer in an ABI Prism 7700 Sequence de-
tector (both from Applied Biosystems, USA). The relative 
level of the housekeeping gene hypoxanthine phosphori-
bosyltransferase (HPRT) was measured. The primers used 
included PAI-1 rat forward GACAATGGAAGAGCAACATG 
and reverse ACCTCGATCTTGACCTTTTG, PAI-1 mouse 
forward ACAGCCTTTGTCATCTCAGCC and reverse 
CCGAACCACAAAGAGAAAGGA, and HPRT forward CTC 
ATGGACTGATTATGGACAGGAC and reverse GCAGG 
TCAGCAAAGAACTTATAGCC.
Data were obtained using a sequence detector software 
(Applied Biosystems) and are reported as relative increase 
using the method of 2−ΔΔCt (13).
Biochemical and hormonal serum analysis
Serum T3 and T4 concentrations were quantified using 
specific chemiluminescent immunometric assays (Advia 
Centaur, Bayer Corporation, USA). PAI-1 serum concen-
tration was determined using a commercial kit (Innovative 
Research, USA). 
Statistical analysis
Data are reported as means ± SEM. Statistical sig-
nificance was assessed by the Student t-test for unpaired 
samples. Differences were considered to be significant 
when P < 0.05.
Results
During the 3-week treatment period, the Hyper group 
treated with T4 presented an increased energy intake when 
compared to the control group. Both groups gained body 
weight during treatment, but the control group gained more 
weight (Table 1). However, the weights of retroperitoneal 
and epididymal adipose tissues were not different (Table 
1). In order to validate this protocol, we quantified the thy-
roid hormones in the serum of treated animals. As shown 
in Table 1, thyroxine injection increased both T4 and T3 
serum concentrations (Hyper) when compared to those of 
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saline-treated rats (control). 
PAI-1 gene expression in epididymal and retroperito-
neal adipose tissues and PAI-1 serum concentrations was 
similar in both the Hyper and control groups (Table 1); 
however, in 3T3-L1 adipocytes, treatment with T4 or T3 for 
24 h increased PAI-1 gene expression 1.6 and 1.9 times, 
respectively (Figure 1). 
Discussion
The results of the present study show that thyroid 
hormones stimulate the expression of the PAI-1 gene in 
3T3-L1 cells; however, we did not observe changes in 
adipose tissue gene expression of PAI-1 in vivo, despite 
the increase of T4 and T3 serum concentrations. 
Numerous studies have shown that thyroid hormones 
increase the metabolic rate and accelerate practically all 
metabolic pathways, with a consequent increase in ATP 
turnover and heat production (14); however, in the pres-
ent study, treatment with T4 for 3 weeks did not modify the 
adiposity of the animals, as shown by unchanged adipose 
tissue weights. This could be explained by the increase 
in energy intake observed in the Hyper group (T4-treated 
animals) in comparison to the control group. In fact, it has 
been recently reported that T4 treatment increases food 
intake (15).
In our model, the in vivo T4 treatment did not modify 
PAI-1 gene expression in RET and EPI, or in serum PAI-1 
concentration. On the other hand, the addition of T3 or T4 
to the culture medium caused an increase in PAI-1 gene 
expression in 3T3-L1 adipocytes. As far as we know, no 
investigation has reported the presence of deiodinase 
(the enzyme that converts T4 to T3) in 3T3-L1 adipocytes, 
suggesting non-genomic (T4 effect) and genomic ef-
fects (T3 effect) of thyroid hormones on PAI-1 expression 
in these cells. 
These results demonstrate that adipocytes present 
different responses to thyroid hormones when considering 
in vivo and in vitro experiments. Other investigations have 
also demonstrated different in vivo and in vitro responses. 
Growth hormone treatment has been reported to increase 
PAI-1 secretion by 3T3-L1 adipocytes (16) and to decrease 
PAI-1 serum concentration in vivo (17). Similarly, the inges-
tion of an n-3 PUFA-enriched diet for 60 days did not affect 
adiponectin gene expression or serum adiponectin concen-
tration in vivo, whereas treatment with eicosapentaenoic 
and docosahexaenoic fatty acids decreased adiponectin 
mRNA levels in 3T3-L1 adipocytes (18). 
Figure 1. PAI-1 gene expression by 3T3-L1 adipocytes treated 
for 24 h with T4 or T3 (N = 12/group). Data (means ± SEM) are 
reported as a percentage of the control group. *P < 0.05 vs con-
trol group (unpaired Student t-test).
Table 1. Body weight gain, energy intake, weight of retroperitoneal and epididymal adipose 
tissue, serum concentrations of T4 and T3, PAI-1 gene expression in retroperitoneal and 
epididymal adipose tissues, and serum concentration in rats treated with saline (control) or 
T4 (Hyper).
 Control Hyper
Body weight gain (g) 88.4 ± 11.0 60.9 ± 7.8*
Energy intake (kcal/3 weeks) 524.9 ± 41.3 679.9 ± 48.8*
Retroperitoneal adipose tissue (g) 4.2 ± 0.5 3.4 ± 0.4
Epididymal adipose tissue (g) 4.0 ± 0.3 3.9 ± 0.4
3,3′,5-Triiodothyronine (T3) (ng/dL) 87.0 ± 6.4 438.4 ± 39.5*
Thyroxine (T4) (mg/dL) 4.4 ± 0.5 17.1 ± 0.6*
PAI-1 gene expression in retroperitoneal adipose tissue (%) 100.0 ± 12.4 70.9 ± 12.8
PAI-1 gene expression in epididymal adipose tissue (%) 100.0 ± 10.8 72.7 ± 14.9
PAI-1 serum concentration (pg/mL) 104.8 ± 9.1 65.8 ± 11.8
Data are reported as means ± SEM for 10 animals per group. *P < 0.05 vs control group 
(unpaired Student t-test).
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The diverse in vivo and in vitro effects of thyroid hor-
mones on PAI-1 gene expression regulation are not related 
to the inhibitory effect of T4 on thyroid-stimulating hormone 
(TSH) secretion, since the literature has not shown any 
relationship between TSH and PAI-1 serum concentration 
(19). However, it could be suggested that the lower amount 
of thyroid hormone receptors and deiodinase present in 
white adipose tissue than in brain, liver, brown adipose 
tissue, and kidney may be involved in this process. 
In addition, the low blood flow in white adipose tissue 
in comparison to other tissue types (20) could contribute to 
hormone distribution in vivo, suggesting that lower amounts 
of T4 and T3 were achieved in adipocytes in vivo in com-
parison to the in vitro study. 
This study demonstrates that thyroid hormones have 
different effects in relation to PAI-1 gene expression in 
adipocytes in the intact rat (in vivo study) and in cultured 
adipocytes (in vitro study). Further studies are required to 
better elucidate the diverse in vivo and in vitro effects of 
thyroid hormone on adipocytes PAI-1 gene expression.
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